Natural products targeting cellular processes common in Parkinson's disease and multiple sclerosis

Abstract

The hallmarks of Parkinson's disease (PD) include the loss of dopaminergic neurons and formation of Lewy bodies, whereas multiple sclerosis (MS) is an autoimmune disorder with damaged myelin sheaths and axonal loss. Despite their distinct etiologies, mounting evidence in recent years suggests that neuroinflammation, oxidative stress, and infiltration of the blood-brain barrier (BBB) all play crucial roles in both diseases. It is also recognized that therapeutic advances against one neurodegenerative disorder are likely useful in targeting the other. As current drugs in clinical settings exhibit low efficacy and toxic side effects with long-term usages, the use of natural products (NPs) as treatment modalities has attracted growing attention. This mini-review summarizes the applications of natural compounds to targeting diverse cellular processes inherent in PD and MS, with the emphasis placed on their neuroprotective and immune-regulating potentials in cellular and animal models. By reviewing the many similarities between PD and MS and NPs according to their functions, it becomes evident that some NPs studied for one disease are likely repurposable for the other. A review from this perspective can provide insights into the search for and utilization of NPs in treating the similar cellular processes common in major neurodegenerative diseases.

Ellagic acid effects on disease severity, levels of cytokines and T-bet, RORγt, and GATA3 genes expression in multiple sclerosis patients: a multicentral-triple blind randomized clinical trial

“…It is also possible that ellagic acid reduces oxidative stress and apoptosis by reducing Th17 cells and IL-17 cytokine levels in oligodendrocytes. By decreasing IL-17 levels, ellagic acid also facilitates the regeneration process of myelin and removes obstacles to the maturation of oligodendrocytes and increases their survival ( 66 , 67 ).…”

Multifunctional Nanotheranostics for Overcoming the Blood–Brain Barrier

“…Similarly, curcumin (a polyphenol extract from turmeric) modulates T-cell differentiation, thereby diminishing the clinical severity of EAE. [344] In recent years, liposomes have been broadly used in MS management, especially in early detection and prognosis. Overall, removing apoptotic cells is critical in cases of the loss of selftolerance-triggering autoimmune diseases (e.g., MS).…”

“…Similarly, curcumin (a polyphenol extract from turmeric) modulates T‐cell differentiation, thereby diminishing the clinical severity of EAE. [ 344 ]…”

Editorial: High altitude medicinal plants and their bioactive compounds for the prevention of oxidative stress-induced diseases and disorders

“…have been discovered from natural sources for their antimicrobial, cardioprotective, anti-inflammatory, anticancer and chemoprotective activities. There is considerable evidence to suggest that these phytochemicals are beneficial to health on an epidemiological and clinical level ( Chan et al, 2023 ; Du et al, 2023 ; Rahaman et al, 2023 ; Xu et al, 2023 ; Zhou et al, 2023 ; Zhu et al, 2023 ).…”